Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis.
Biomarkers
Neutrophil-to-lymphocyte ratio
Platelet-to-lymphocyte ratio
Platelets, Neutrophils, Lymphocytes
Rectal cancer
Recurrence
Survival
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
13 Feb 2023
13 Feb 2023
Historique:
received:
05
07
2022
accepted:
30
12
2022
entrez:
13
2
2023
pubmed:
14
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
Inflammation plays an important role in tumor growth. Novel serum blood biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR), have been proposed as useful prognostic indexes in cancer patients. However, their role in rectal cancer is controversial. A comprehensive literature review was conducted including MEDLINE/Pubmed, EMBASE, SCOPUS, and the Cochrane Database of Systematic Reviews through May 2022. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Quality was appraised with the Methodological Index for Non-Randomized Studies (MINORS) tool. Aim of the study was to summarize available literature on PLR, NLR, and LMR in patients with rectal cancer undergoing resection. Forty-seven observational studies (14,205 patients) were included; there were 42 retrospective and 5 prospective cohort studies with an average MINORS score of 14.6 (range: 12-18). Worse overall survival was associated with high NLR (HR 1.81; 95%CI 1.52-2.15; p < 0.001), high PLR (HR 1.24; 95%CI 1.06-1.46; p = 0.009), and low LMR (HR 0.67; 95%CI 0.49-0.91; p = 0.01). High NLR and low LMR were also associated with disease-free-survival (HR 1.68; 95%CI 1.35-2.08; p < 0.001 and HR 0.71; 95%CI 0.58-0.87; p < 0.001, respectively). NLR, PLR, and LMR are independent clinical predictors for overall survival in patients with rectal cancer treated with curative surgery. NLR and LMR are also good predictors for disease free survival. These biomarkers, which are readily available, appear optimal prognostic indexes and may help clinicians predict the prognosis of rectal cancer and develop individualized treatment strategies.
Sections du résumé
BACKGROUND
BACKGROUND
Inflammation plays an important role in tumor growth. Novel serum blood biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR), have been proposed as useful prognostic indexes in cancer patients. However, their role in rectal cancer is controversial.
METHODS
METHODS
A comprehensive literature review was conducted including MEDLINE/Pubmed, EMBASE, SCOPUS, and the Cochrane Database of Systematic Reviews through May 2022. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Quality was appraised with the Methodological Index for Non-Randomized Studies (MINORS) tool. Aim of the study was to summarize available literature on PLR, NLR, and LMR in patients with rectal cancer undergoing resection.
RESULTS
RESULTS
Forty-seven observational studies (14,205 patients) were included; there were 42 retrospective and 5 prospective cohort studies with an average MINORS score of 14.6 (range: 12-18). Worse overall survival was associated with high NLR (HR 1.81; 95%CI 1.52-2.15; p < 0.001), high PLR (HR 1.24; 95%CI 1.06-1.46; p = 0.009), and low LMR (HR 0.67; 95%CI 0.49-0.91; p = 0.01). High NLR and low LMR were also associated with disease-free-survival (HR 1.68; 95%CI 1.35-2.08; p < 0.001 and HR 0.71; 95%CI 0.58-0.87; p < 0.001, respectively).
CONCLUSIONS
CONCLUSIONS
NLR, PLR, and LMR are independent clinical predictors for overall survival in patients with rectal cancer treated with curative surgery. NLR and LMR are also good predictors for disease free survival. These biomarkers, which are readily available, appear optimal prognostic indexes and may help clinicians predict the prognosis of rectal cancer and develop individualized treatment strategies.
Identifiants
pubmed: 36781510
doi: 10.1007/s00423-023-02786-8
pii: 10.1007/s00423-023-02786-8
doi:
Substances chimiques
Biomarkers
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
85Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012: Global Cancer Statistics, 2012. CA Cancer J Clin marzo 65(2):87–108
doi: 10.3322/caac.21262
Heald RJ, Husband EM, Ryall RDH (2005) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69(10):613–6
doi: 10.1002/bjs.1800691019
Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al (2001) Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer. N Engl J Med 345(9):638–46
pubmed: 11547717
doi: 10.1056/NEJMoa010580
Breugom AJ, Swets M, Bosset JF, Collette L, Sainato A, Cionini L et al (2015) Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol febbraio 16(2):200–207
doi: 10.1016/S1470-2045(14)71199-4
Slaney G (1971) Results of treatment of carcinoma of the colon and rectum. Mod Trends Surg 3:69–89
pubmed: 5120472
Kusters M, Marijnen CAM, van de Velde CJH, Rutten HJT, Lahaye MJ, Kim JH et al (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol EJSO maggio 36(5):470–476
doi: 10.1016/j.ejso.2009.11.011
Marks JH, Huang R, McKeever D, Greenfield M (2016) Outcomes in 132 patients following laparoscopic total mesorectal excision (TME) for rectal cancer with greater than 5-year follow-up. Surg Endosc gennaio 30(1):307–314
doi: 10.1007/s00464-015-4210-1
Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis: Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer. Int J Cancer 134(10):2403–13
pubmed: 24122750
doi: 10.1002/ijc.28536
Sierko E, Wojtukiewicz MZ (2004) Platelets and Angiogenesis in Malignancy. Semin Thromb Hemost febbraio 30(1):95–108
doi: 10.1055/s-2004-822974
Grivennikov SI, Greten FR, Karin M (2010) Immunity, Inflammation, and Cancer. Cell marzo 140(6):883–899
doi: 10.1016/j.cell.2010.01.025
Feng JF, Huang Y, Zhao Q, Chen QX (2013) Clinical Significance of Preoperative Neutrophil Lymphocyte Ratio versus Platelet Lymphocyte Ratio in Patients with Small Cell Carcinoma of the Esophagus. Sci World J 2013:1–7
Gunaldi M, Goksu S, Erdem D, Gunduz S, Okuturlar Y, Tiken E et al (2015) Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med 8(4):5937–5942
pubmed: 26131188
pmcid: 4483800
Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107(6):988–93
pubmed: 22878374
pmcid: 3464773
doi: 10.1038/bjc.2012.354
Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F et al (2009) Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg aprile 197(4):466–472
doi: 10.1016/j.amjsurg.2007.12.057
Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ et al (2012) Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers maggio 17(3):216–222
doi: 10.3109/1354750X.2012.656705
Szkandera J, Pichler M, Absenger G, Stotz M, Arminger F, Weissmueller M et al (2014) The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg agosto 208(2):210–214
doi: 10.1016/j.amjsurg.2013.10.030
Choi WJ, Cleghorn MC, Jiang H, Jackson TD, Okrainec A, Quereshy FA (2015) Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Ann Surg Oncol dicembre 22(Suppl 3):S603-613
doi: 10.1245/s10434-015-4571-7
Gu X, Gao XS, Qin S, Li X, Qi X, Ma M et al (2016) Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer. PLoS ONE 11(9):e0163523
pubmed: 27658306
pmcid: 5033452
doi: 10.1371/journal.pone.0163523
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol ottobre 62(10):e1-34
doi: 10.1016/j.jclinepi.2009.06.006
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (MINORS): development and validation of a new instrument: Methodological index for non-randomized studies. ANZ J Surg settembre 73(9):712–716
doi: 10.1046/j.1445-2197.2003.02748.x
R Core Team (2021) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/ . Accessed 30 Sept 2022
Liu N, Zhou Y, Lee JJ (2021) IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol dicembre 21(1):111
doi: 10.1186/s12874-021-01308-8
Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health novembre 22(4):153–160
doi: 10.1136/ebmental-2019-300117
Viechtbauer W. (2010) Conducting Meta-Analyses in R with the metafor Package. J Stat Softw 36(3). disponibile su: http://www.jstatsoft.org/v36/i03/ . Accessed 30 Sept 2022
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–34
pubmed: 9310563
pmcid: 2127453
doi: 10.1136/bmj.315.7109.629
Duval S, Tweedie R (2000) Trim and Fill: A Simple Funnel-Plot-Based Method of Testing and Adjusting for Publication Bias in Meta-Analysis. Biometrics giugno 56(2):455–463
doi: 10.1111/j.0006-341X.2000.00455.x
Liu H, Liu G, Bao Q, Sun W, Bao H, Bi L et al (2010) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma. J Gastrointest Cancer giugno 41(2):116–120
doi: 10.1007/s12029-009-9125-4
Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC (2012) Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel 14(10):e701-707
Kim IY, You SH, Kim YW (2014) Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer. BMC Surg 14:94
pubmed: 25406793
pmcid: 4242604
doi: 10.1186/1471-2482-14-94
Shen L, Zhang H, Liang L, Li G, Fan M, Wu Y et al (2014) Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Radiat Oncol Lond Engl 9:295
doi: 10.1186/s13014-014-0295-2
Nagasaki T, Akiyoshi T, Fujimoto Y, Konishi T, Nagayama S, Fukunaga Y et al (2015) Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy. Dig Surg 32(6):496–503
pubmed: 26544755
doi: 10.1159/000441396
Toiyama Y, Inoue Y, Kawamura M, Kawamoto A, Okugawa Y, Hiro J et al (2015) Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. Int Surg febbraio 100(2):199–207
doi: 10.9738/INTSURG-D-13-00178.1
Xiao WW, Zhang LN, You KY, Huang R, Yu X, Ding PR et al (2015) A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision. J Cancer 6(7):616–622
pubmed: 26078791
pmcid: 4466410
doi: 10.7150/jca.11727
Hodek M, Sirák I, Ferko A, Örhalmi J, Hovorková E, HadžiNikolov D et al (2016) Neoadjuvant chemoradiotherapy of rectal carcinoma : Baseline hematologic parameters influencing outcomes. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al 192(9):632–40
doi: 10.1007/s00066-016-0988-6
Li H, Song J, Cao M, Wang G, Li L, Zhang B et al (2016) Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer. Int Immunopharmacol 40:327–331
pubmed: 27664571
doi: 10.1016/j.intimp.2016.09.014
Lino-Silva LS, Salcedo-Hernández RA, Ruiz-García EB, García-Pérez L, Herrera-Gómez Á (2016) Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy. Med Arch Sarajevo Bosnia Herzeg 70(4):256–60
Wu QB, Wang M, Hu T, He WB, Wang ZQ (2016) Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer. Medicine (Baltimore) 95(44):e4945
pubmed: 27858839
doi: 10.1097/MD.0000000000004945
Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ et al (2017) Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer. OncoTargets Ther 10:5575–5583
doi: 10.2147/OTT.S146697
Jung SW, Park IJ, Oh SH, Yeom SS, Lee JL, Yoon YS et al (2017) Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer. Oncotarget 8(35):59757–65
pubmed: 28938679
pmcid: 5601775
doi: 10.18632/oncotarget.15760
Runau F, Collins A, Fenech GA, Ford E, Dimitriou N, Chaudhri S et al (2017) A single institution’s long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy. Int J Colorectal Dis marzo 32(3):341–348
doi: 10.1007/s00384-016-2712-5
Shen J, Zhu Y, Wu W, Zhang L, Ju H, Fan Y et al (2017) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Med Sci Monit Int Med J Exp Clin Res 23:315–24
Sung S, Son SH, Park EY, Kay CS (2017) Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy. PLoS ONE 12(3):e0173955
pubmed: 28291841
pmcid: 5349688
doi: 10.1371/journal.pone.0173955
Zhao J, Xu J, Zhang R (2017) Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery. Med Sci Monit Int Med J Exp Clin Res 23:4826–33
Abe S, Kawai K, Nozawa H, Hata K, Kiyomatsu T, Morikawa T et al (2018) LMR predicts outcome in patients after preoperative chemoradiotherapy for stage II-III rectal cancer. J Surg Res febbraio 222:122–131
doi: 10.1016/j.jss.2017.09.053
Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V (2018) Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection. J Gastrointest Surg Off J Soc Surg Aliment Tract 22(9):1611–8
doi: 10.1007/s11605-018-3781-2
Vallard A, Garcia MA, Diao P, Espenel S, de Laroche G, Guy JB et al (2018) Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker. Oncotarget 9(32):22368–82
pubmed: 29854285
pmcid: 5976471
doi: 10.18632/oncotarget.25023
Ward WH, Goel N, Ruth KJ, Esposito AC, Lambreton F, Sigurdson ER et al (2018) Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma. J Surg Res dicembre 232:275–282
doi: 10.1016/j.jss.2018.06.060
Bai XH, Zou GL, Ding Z, Zhao R, Zhe H, Wang L (2019) The role of neutrophil-to-lymphocyte ratio (NLR) in predicting small bowel toxicity and outcome for rectal cancer patients who received chemoradiotherapy. Int J Radiat Res 17(2):309–315
Cha YJ, Park EJ, Baik SH, Lee KY, Kang J (2019) Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis. PLoS ONE 14(3):e0214415
pubmed: 30901357
pmcid: 6430363
doi: 10.1371/journal.pone.0214415
Dudani S, Marginean H, Tang PA, Monzon JG, Raissouni S, Asmis TR et al (2019) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer 19(1):664
pubmed: 31277604
pmcid: 6612202
doi: 10.1186/s12885-019-5892-x
Jeon BH, Shin US, Moon SM, Choi JI, Kim MS, Kim KH et al (2019) Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery. Ann Coloproctology aprile 35(2):100–106
doi: 10.3393/ac.2018.10.01
Kim SY, Moon CM, Yoon HJ, Kim BS, Lim JY, Kim TO et al (2019) Diffuse splenic FDG uptake is predictive of clinical outcomes in patients with rectal cancer. Sci Rep 9(1):1313
pubmed: 30718566
pmcid: 6361940
doi: 10.1038/s41598-018-35912-4
Kim TG, Park W, Kim H, Choi DH, Park HC, Kim SH et al (2019) Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy. Tumori ottobre 105(5):434–440
doi: 10.1177/0300891618792476
Yamamoto A, Toiyama Y, Okugawa Y, Oki S, Ide S, Saigusa S et al (2019) Clinical Implications of Pretreatment: Lymphocyte-to-Monocyte Ratio in Patients With Rectal Cancer Receiving Preoperative Chemoradiotherapy. Dis Colon Rectum febbraio 62(2):171–180
doi: 10.1097/DCR.0000000000001245
Zhang X, Li J, Peng Q, Huang Y, Tang L, Zhuang Q et al (2019) Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy. Cancer Manag Res 11:191–199
pubmed: 30636893
doi: 10.2147/CMAR.S187559
Zhang YY, Li WQ, Li ZF, Guo XH, Zhou SK, Lin A et al (2019) Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer. Front Oncol 9:960
pubmed: 31612109
pmcid: 6769073
doi: 10.3389/fonc.2019.00960
Braun LH, Baumann D, Zwirner K, Eipper E, Hauth F, Peter A et al. (2019) Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable? Int J Mol Sci 20(10):2448
Dolan RD, Alwahid M, McSorley ST, Park JH, Stevenson RP, Roxburgh CS et al (2020) A comparison of the prognostic value of composite ratios and cumulative scores in patients with operable rectal cancer. Sci Rep 10(1):17965
pubmed: 33087753
pmcid: 7578034
doi: 10.1038/s41598-020-73909-0
Fülöp ZZ, Gurzu S, Fülöp RL, Bara TJ, Tímár J, Drágus E et al. (2020) Prognostic Impact of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratio, in Patients with Rectal Cancer: A Retrospective Study of 1052 Patients. J Pers Med 10(4):173
Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO et al (2020) Association of Body Composition with Long-Term Survival in Non-metastatic Rectal Cancer Patients. Cancer Res Treat aprile 52(2):563–572
doi: 10.4143/crt.2019.249
Huang Z, Wang X, Zou Q, Zhuang Z, Xie Y, Cai D et al (2020) High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer. Int J Colorectal Dis aprile 35(4):695–704
doi: 10.1007/s00384-020-03528-8
Ke TM, Lin LC, Huang CC, Chien YW, Ting WC, Yang CC (2020) High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy. Medicine (Baltimore) 99(17):e19877
pubmed: 32332656
doi: 10.1097/MD.0000000000019877
Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H (2020) Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer. BMC Cancer 20(1):208
pubmed: 32164623
pmcid: 7066735
doi: 10.1186/s12885-020-6698-6
Yoshida D, Minami K, Sugiyama M, Ota M, Ikebe M, Morita M et al (2020) Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Stage I-II Rectal Cancer Patients. J Surg Res gennaio 245:281–287
doi: 10.1016/j.jss.2019.07.072
Zhang Y, Liu X, Xu M, Chen K, Li S, Guan G (2020) Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Sci Rep 10(1):8017
pubmed: 32415197
pmcid: 7228917
doi: 10.1038/s41598-020-64684-z
Ergen ŞA, Barlas C, Yıldırım C, Öksüz DÇ (2021) Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy. J Gastrointest Cancer marzo 53(1):151–160
doi: 10.1007/s12029-020-00578-7
Huang CM, Huang MY, Tsai HL, Huang CW, Su WC, Chang TK et al. (2021) Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Cancers 13(18):4589
Sari R, Kaya S, Altin O, Tuzun S, Altuntas Y, Kucuk H (2021) Prognostic significance of systemic inflammatory markers in rectal cancer. Ann Med Res 28(1):101
doi: 10.5455/annalsmedres.2020.06.596
Wang P, Wang Z, Liu Y, Xie J, Ren Y (2021) Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study. Cancer Radiother J Soc Francaise Radiother Oncol 25(2):147–54
Zhuang Z, Wang X, Huang M, Luo Y, Yu H (2021) Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer. J Gastrointest Oncol aprile 12(2):568–579
doi: 10.21037/jgo-20-479
An SH, Kim IY (2022) Can pretreatment platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict long-term oncologic outcomes after preoperative chemoradiation followed by surgery for locally advanced rectal cancer?. Ann Coloproctology 38:253–261
Yang G, Chang JS, Choi JE, Baek ES, Kim SS, Byun HK et al (2022) Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer. Radiat Oncol dicembre 17(1):100
doi: 10.1186/s13014-022-02065-8
Zhang J, Zhang L, Gou Y, Diao P, Hu Y (2022) The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients. Sci Rep 12(1):4286
pubmed: 35277532
pmcid: 8917228
doi: 10.1038/s41598-022-07726-y
Rashtak S, Ruan X, Druliner BR, Liu H, Therneau T, Mouchli M et al (2017) Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer. Clin Colorectal Cancer giugno 16(2):115-123.e3
doi: 10.1016/j.clcc.2017.01.008
Hamid HKS, Davis GN, Trejo-Avila M, Igwe PO, Garcia-Marín A (2021) Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis. Surg Oncol giugno 37:101556
doi: 10.1016/j.suronc.2021.101556
Hamid HKS, Emile SH, Davis GN (2022) Prognostic Significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review, Meta-analysis, and Meta-regression. Dis Colon Rectum 65(2):178–87
pubmed: 34775400
doi: 10.1097/DCR.0000000000002291
Edge SB, Compton CC (2010) The American Joint Committee on Cancer. the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol 17(6):1471–1474
Nagtegaal ID, Marijnen CAM, Kranenbarg EK, van de Velde CJH, van Krieken JHJM (2002) Circumferential Margin Involvement Is Still an Important Predictor of Local Recurrence in Rectal Carcinoma: Not One Millimeter but Two Millimeters Is the Limit. Am J Surg Pathol marzo 26(3):350–357
doi: 10.1097/00000478-200203000-00009
Cienfuegos JA, Rotellar F, Baixauli J, Beorlegui C, Sola JJ, Arbea L et al (2015) Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery. Ann Surg Oncol marzo 22(3):916–923
doi: 10.1245/s10434-014-4051-5